The market value for hormones in dosage, excluding contraceptives and antibiotics, in Peru saw fluctuations from 2013 to 2023. In 2023, the value stood at USD 3.51 per capita. Over the last two years, there was a positive trend with a year-on-year percentage increase from 2021 to 2023. The five-year compound annual growth rate (CAGR) from 2018 to 2023 indicates moderate growth. Overall, the market experienced varied dynamics with a notable recovery post-2018 dip.

Future trends to watch for include:

Increasing demand for hormone therapies due to aging populations.
Potential impacts from regulation changes.
Advancements in biotechnologies influencing product development and market expansion.